Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/17/2004 First Published: 11/20/2003


1.		Phase I/II Study of PI-88 in Patients With an Advanced Malignancy or Stage IV Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				PROGEN-PR88201 COMIRB-01-207, NCT00073892

Last Modified: 8/8/2006 First Published: 1/24/2005


2.		Phase II Randomized Study of Docetaxel With Versus Without PI-88 in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				PROGEN-PR88202 AUS-RNSH-0309-183M, NCT00103389


3.		PI-88 in Hepatocellular Carcinoma After Hepatectomy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 to 75				Pharmaceutical / Industry				MG 002 PR88204, NCT00247728


4.		Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				PR88206 PROPIT, XRP6976J/6216, NCT00268593

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute